Analyst Price Targets — OPAL
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| September 3, 2024 7:23 am | Sector Perform | Scotiabank | $5.00 | $3.59 | TheFly | Opal Fuels downgraded at Scotiabank on limited near-term RNG catalysts |
| April 18, 2024 7:16 am | Ryan Todd | Piper Sandler | $8.00 | $4.73 | TheFly | Opal Fuels price target lowered to $8 from $13 at Piper Sandler |
| March 19, 2024 6:51 am | William Grippin | UBS | $8.00 | $4.76 | StreetInsider | OPAL Fuels Inc (OPAL) PT Lowered to $8 at UBS |
| December 15, 2022 8:48 am | — | Johnson Rice | $13.00 | $7.41 | Benzinga | Johnson Rice Initiates Coverage On OPAL Fuels with Buy Rating, Announces Price Target of $13 |
| December 5, 2022 7:10 am | — | UBS | $13.00 | $9.41 | Benzinga | UBS Initiates Coverage On OPAL Fuels with Buy Rating, Announces Price Target of $13 |
Latest News for OPAL
[url="]OPAL Fuels[/url] (Nasdaq: OPAL) a leader in the production, marketing, and distribution of renewable and compressed natural gas (RNG and CNG) used as a t
WHITE PLAINS, N.Y.--(BUSINESS WIRE)--OPAL Fuels (Nasdaq: OPAL) a leader in the production, marketing, and distribution of renewable and compressed natural gas (RNG and CNG) used as a transportation fuel for heavy duty trucking, today announced that it has completed the renovation and upgrade of its fueling station in Goshen, California located at 30981 Road 67, Goshen, CA. The enhanced facility is expected to…
[url="]OPAL Fuels[/url] (Nasdaq: OPAL) a leading vertically integrated producer and distributor of renewable natural gas (RNG) welcomed Congressman Eugene Vindm
MANASSAS, Va.--(BUSINESS WIRE)--OPAL Fuels (Nasdaq: OPAL) a leading vertically integrated producer and distributor of renewable natural gas (RNG) welcomed Congressman Eugene Vindman (VA-07) to its RNG facility at the Prince William County Landfill in Manassas, Virginia. The visit included a tour of the facility and a meeting with OPAL Fuels Co-Chief Executive Officer Adam Comora to discuss the role of domestic RNG…
• Initiated Study to Assess the Potential Impact of the Combination of Icovamenib and Low-Dose Semaglutide on Physical Function, Body Weight, Body Composition, Muscle Health, and Metabolic Outcomes
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for OPAL.
U.S. House Trading
No House trades found for OPAL.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.